Publications


Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. Vittorio Canale, Anna Partyka, Rafał Kurczab, Martyna Krawczyk, Tomasz Kos, Grzegorz Satała, Bartłomiej Kubica, Magdalena Jastrzębska-Więsek, Anna Wesołowska, Andrzej J Bojarski, Piotr Popik, Paweł Zajdel
Bioorganic & medicinal chemistry, S0968-0896(17)30359-0 10.1016/j.bmc.2017.03.057
PMID:28391970

Monday, 10 April 2017
The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors. Agnieszka Nikiforuk, Agnieszka Potasiewicz, Tomasz Kos, Piotr Popik
Behavioural brain research, 10.1016/j.bbr.2016.07.023 S0166-4328(16)30451-X
PMID:27435422

Tuesday, 16 August 2016
The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia. Agnieszka Nikiforuk, Małgorzata Hołuj, Tomasz Kos, Piotr Popik
Neuropharmacology, 10.1016/j.neuropharm.2016.01.035 S0028-3908(16)30034-X
PMID:26826431

Thursday, 19 May 2016
The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors. Agnieszka Nikiforuk, Agnieszka Potasiewicz, Dominik Rafa, Karla Drescher, Anton Bespalov, Piotr Popik
Behavioural pharmacology, 10.1097/FBP.0000000000000201
PMID:26580130

Wednesday, 18 November 2015
Anandamide mediates cognitive judgement bias in rats. J Kregiel, N Malek, P Popik, K Starowicz, R Rygula
Neuropharmacology, S0028-3908(15)30101-5 10.1016/j.neuropharm.2015.09.009
PMID:26363193

Monday, 9 November 2015
Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats. Agnieszka Nikiforuk, Tomasz Kos, Małgorzata Hołuj, Agnieszka Potasiewicz, Piotr Popik
Neuropharmacology, S0028-3908(15)30041-1 10.1016/j.neuropharm.2015.07.034
PMID:26232639

Monday, 9 November 2015
Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor. Kinga Sałat, Agata Siwek, Gabriela Starowicz, Tadeusz Librowski, Gabriel Nowak, Urszula Drabik, Ryszard Gajdosz, Piotr Popik
Neuropharmacology, 10.1016/j.neuropharm.2015.07.037 S0028-3908(15)30044-7
PMID:26240948

Sunday, 8 November 2015
Dopamine induces an optimism bias in rats-Pharmacological proof for the translational validity of the ambiguous-cue interpretation test. J Kregiel, J Golebiowska, P Popik, R Rygula
Behavioural brain research, S0166-4328(15)30231-X 10.1016/j.bbr.2015.10.020
PMID:26462571

Wednesday, 4 November 2015
Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors. Małgorzata Hołuj, Piotr Popik, Agnieszka Nikiforuk
Behavioural pharmacology, 10.1097/FBP.0000000000000132
PMID:25769091

Wednesday, 4 November 2015
Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor. A Potasiewicz, T Kos, F Ravazzini, G Puia, H R Arias, P Popik, A Nikiforuk
British journal of pharmacology, 10.1111/bph.13277
PMID:26276349

Thursday, 29 October 2015